Evidence map›Paper›PMID 39759435›Full record

ArticleJACC. Advances2025

Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction.

Stephanie J Rowe, Elizabeth D Paratz, Louise Fahy, Kristel Janssens, Luke W Spencer, Paolo D'Ambrosio, Geoff Strange, David L Prior, David Playford, Andre La Gerche

Abstract read
In one paragraph

Article in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stephanie J RoweHEART Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia.
Elizabeth D ParatzHEART Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia.
Louise FahyHEART Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia.
Kristel JanssensHEART Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia.
Luke W SpencerHEART Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia.
Paolo D'AmbrosioHEART Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia.
Geoff StrangeSchool of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia.
David L PriorDepartment of Cardiology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
David PlayfordSchool of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia.
Andre La GercheHEART Lab, St Vincent's Institute of Medical Research, Fitzroy, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In patients with preserved left ventricular ejection fraction (LVEF), small ventricular size has been associated with reduced functional capacity, but its impact on clinical outcomes is unclear. Objectives: The goal of this study was to determine the relationship between small heart size and premature mortality within a large multicenter adult patient cohort with transthoracic echocardiographic examinations. Methods: We divided 366,484 individuals with LVEF ≥50% (including a subset of 279,442 individuals with high-normal LVEF ≥60%) by sex and increasing quartiles for LV end-diastolic volume (LVEDV), LVEDV indexed to body surface area (LVEDVi), and LV end-diastolic diameter to assess associations with 5-year mortality through linkage with the National Death Index. Results: During approximately 2 million person-years of follow-up, 65,241 deaths occurred. Increasing LV chamber size was associated with reduced odds of 5-year all-cause mortality, particularly for higher LVEF. As compared with the larger quartiles, the smallest cardiac size quartiles were associated with higher 5-year all-cause mortality, even after adjusting for age. The smallest LVEDVi quartile was associated with a 14% to 18% higher odds of 5-year all-cause mortality, with a greater effect with high-normal LVEF. There was a U-shaped relationship between LV chamber size and all-cause mortality. For cardiovascular-related mortality, females in the smallest LVEDVi quartile had a 17% increased odds of mortality, which increased to 30% in those with LVEF ≥60%. In men, there was no significant association between smallest cardiac size and cardiovascular-related mortality. Conclusions: In individuals with normal LVEF, small ventricular size is associated with increased mortality, particularly among females and those with higher LVEF.

Indexed as

cardiac sizeheart failureHFpEFHFrEF

Identifiers

PMID39759435
PMCPMC11699313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.